Literature DB >> 2676485

Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats.

S M Brichard1, A M Pottier, J C Henquin.   

Abstract

The trace element vanadium (V) exerts insulin-like effects in vitro and lowers blood glucose in streptozotocin-diabetic rats. The present study examined whether V can also improve glucose homeostasis in genetically obese, insulin-resistant rats. Na3VO4 was administered for 3 months in water and food to Zucker fa/fa rats. Since these V rats reduced their food intake by about 30% compared to controls (C), one group of untreated rats was pair-fed (P-F) with V rats. In the fed state, the insulin/glucose ratio was lower in V rats than in P-F or C rats, merely because of a decrease (approximately 50%) in plasma insulin levels. Tolerance to oral glucose was improved in V rats only; the integrated glucose response was 30% lower than that in P-F or C rats. Insulin levels were also lower in V rats, but the integrated response was not consistently decreased. During an iv glucose tolerance test, the glucose disappearance rate was 50% higher in V rats than in the other two groups. An iv arginine test clearly showed that B-cell responsiveness was not increased in V rats. Insulin sensitivity, assessed by insulin-induced hypoglycemia, was similar in V and P-F rats and slightly better than that in C rats. In conclusion, oral vanadate produces a sustained improvement of glucose homeostasis by an insulin-like, largely body weight-independent mechanism in genetically insulin-resistant rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676485     DOI: 10.1210/endo-125-5-2510

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Vanadium and diabetes. What about vanadium toxicity?

Authors:  J L Domingo
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

2.  Effect of vanadium on renal Na+,K+-ATPase activity in diabetic rats: a possible role of leptin.

Authors:  Mohamed D Morsy; Hesham A Abdel-Razek; Osama M Osman
Journal:  J Physiol Biochem       Date:  2010-10-07       Impact factor: 4.158

Review 3.  Anti-diabetic and toxic effects of vanadium compounds.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

4.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 5.  Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.

Authors:  I G Fantus; G Deragon; R Lai; S Tang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 6.  Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.

Authors:  I G Fantus; E Tsiani
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases.

Authors:  Y Shechter; J Li; J Meyerovitch; D Gefel; R Bruck; G Elberg; D S Miller; A Shisheva
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

8.  Vanadate induces normolipidemia and a reduction in the levels of hepatic lipogenic enzymes in obese Zucker rat.

Authors:  S Pugazhenthi; A Hussain; B Yu; R W Brownsey; J F Angel; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

9.  In vivo effects of peroxovanadium compounds in BB rats.

Authors:  J F Yale; C Vigeant; C Nardolillo; Q Chu; J Z Yu; A Shaver; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 10.  Vanadium and diabetes.

Authors:  P Poucheret; S Verma; M D Grynpas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.